The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism

Sebastián, Carlos, Zwaans, Bernadette M.M., Silberman, Dafne M., Gymrek, Melissa, Goren, Alon, Zhong, Lei, Ram, Oren, Truelove, Jessica +16 more·2012·Cell

Cited by (664)

Items 201–300 of 664

  1. SIRT6 Suppresses Cancer Stem-like Capacity in Tumors with PI3K Activation Independently of Its Deacetylase Activity
    Rafael M. Ioris, Mirco Galiè, Giorgio Ramadori, Jason G. Anderson, Anne Charollais, Georgia Konstantinidou, Xavier Brénachot, Ebru Aras, Algera Goga, Nicholas Ceglia et al. · 2017 · Cell Reports
  2. SIRT6 transcriptionally regulates fatty acid transport by suppressing PPARγ
    Danish Khan, Tarannum Ara, Venkatraman Ravi, Raksha Rajagopal, Himani Tandon, Jayadevan Parvathy, Edward A. Gonzalez, Ninitha Asirvatham‐Jeyaraj, Swati Krishna, Sneha Mishra et al. · 2021 · Cell Reports
  3. Sirtuin 6 inhibition protects against glucocorticoid-induced skeletal muscle atrophy by regulating IGF/PI3K/AKT signaling
    Sneha Mishra, Claudia Cosentino, Ankit Kumar Tamta, Danish Khan, Shalini Srinivasan, Venkatraman Ravi, Elena Abbotto, Bangalore Prabhashankar Arathi, Shweta Anil Kumar, Aditi Jain et al. · 2022 · Nature Communications
  4. Astragaloside IV sensitizes non–small cell lung cancer cells to gefitinib potentially via regulation of SIRT6
    Peng-Chen Dai, De-Ling Liu, Lei Zhang, Jia Ye, Qing Wang, Hong-Wen Zhang, Lin Xiu-hua, Guoxiang Lai · 2017 · Tumor Biology
  5. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer
    Dinoop Ravindran Menon, Heinz Hammerlindl, Joachim Torrano, Helmut Schaider, Mayumi Fujita · 2020 · Theranostics
  6. Caloric restriction induced epigenetic effects on aging
    Jingfang Zhai, William H. Kongsberg, Yinbo Pan, Canhua Hao, Xiaojing Wang, Jie Yun Sun · 2023 · Frontiers in Cell and Developmental Biology
  7. Increased Amino Acid Uptake Supports Autophagy-Deficient Cell Survival upon Glutamine Deprivation
    Nan Zhang, Xin Ping Yang, Fengjie Yuan, Luyao Zhang, Yanan Wang, Lina Wang, Zebin Mao, Jianyuan Luo, Hongquan Zhang, Wei‐Guo Zhu et al. · 2018 · Cell Reports
  8. Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D 3 in colorectal cancer
    Jialin Shang, Zhehui Zhu, Ying‐Yi Chen, Jinglue Song, Yuji Huang, Kun Song, Jie Zhong, Xinyuan Xu, Jiacheng Wei, Chengxiang Wang et al. · 2020 · Theranostics
  9. Sirt6 regulates lifespan in Drosophila melanogaster
    Jackson R. Taylor, Jason G. Wood, Evan Mizerak, Samuel J. Hinthorn, Julianna Liu, Matthew Finn, Sarah Gordon, Louis Zingas, Cheng-Yi Chang, Mark A. Klein et al. · 2022 · Proceedings of the National Academy of Sciences
  10. Posttranslational modification of Sirt6 activity by peroxynitrite
    Shuqun Hu, Hua Liu, Yonju Ha, Xuemei Luo, Massoud Motamedi, Mahesh P. Gupta, Jian‐xing Ma, Ronald G. Tilton, Wenbo Zhang · 2014 · Free Radical Biology and Medicine
  11. NAD+: A key metabolic regulator with great therapeutic potential
    Ghazal Sultani, Azrah Samsudeen, Brenna Osborne, Nigel A. Turner · 2017 · Journal of Neuroendocrinology
  12. Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6
    Marci Wood, Stacia Rymarchyk, Song Guo Zheng, Yana Cen · 2017 · Archives of Biochemistry and Biophysics
  13. Quercetin based derivatives as sirtuin inhibitors
    Vladimír Heger, Jonna Tyni, Attila Hunyadi, Ľubica Horáková, Maija K. Lahtela-Kakkonen, Minna Rahnasto‐Rilla · 2019 · Biomedicine & Pharmacotherapy
  14. Sirtuin 6 promotes transforming growth factor‐β1/H 2 O 2 / HOC l‐mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence
    Xinxia Feng, Jing Luo, Mei Liu, Wei Yan, Zhenzhen Zhou, Yujia Xia, Wei Tu, Peiyuan Li, Zuo‐Hua Feng, Dean Tian · 2015 · Cancer Science
  15. Multivalent interactions drive nucleosome binding and efficient chromatin deacetylation by SIRT6
    Wallace H. Liu, Jie Zheng, Jessica L. Feldman, Mark A. Klein, Vyacheslav I. Kuznetsov, Craig L. Peterson, Patrick R. Griffin, John M. Denu · 2020 · Nature Communications
  16. Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling
    Kezheng Peng, Chenye Zeng, Yuqi Gao, Binliang Liu, Liyuan Li, Kang Xu, Yuemiao Yin, Ying Qiu, Mingkui Zhang, Fei Ma et al. · 2023 · Acta Pharmaceutica Sinica B
  17. Genome-wide analysis of functional sirtuin chromatin targets in yeast
    Mingguang Li, Veena Valsakumar, Kunal Poorey, Stefan Bekiranov, Jeffrey S. Smith · 2013 · Genome biology
  18. Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer
    Guoyu Huang, Jun Cheng, Fudong Yu, Xisheng Liu, Chenwei Yuan, Chenchen Liu, Xiao-Lei Chen, Zhihai Peng · 2016 · Oncology Reports
  19. Sirtuins Expression and Their Role in Retinal Diseases
    Sankarathi Balaiya, Khaled K. Abu‐Amero, Altaf A. Kondkar, K V Chalam · 2017 · Oxidative Medicine and Cellular Longevity
  20. NAD+ Deficits in Age-Related Diseases and Cancer
    Amanda Garrido, Nabil Djouder · 2017 · Trends in cancer
  21. SIRT6 histone deacetylase functions as a potential oncogene in human melanoma
    Liz M. Garcia‐Peterson, Mary Ann Ndiaye, Chandra K. Singh, Gagan Chhabra, Wei Huang, Nihal Ahmad · 2017 · Genes & Cancer
  22. Modulation of p53 during bacterial infections
    Christine Siegl, Thomas Rudel · 2015 · Nature Reviews Microbiology
  23. Mechanism of activation for the sirtuin 6 protein deacylase
    Mark A. Klein, Can Liu, Vyacheslav I. Kuznetsov, John B. Feltenberger, Weiping Tang, John M. Denu · 2020 · Journal of Biological Chemistry
  24. A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activity
    Prashanth Kumar Bajpe, Anirudh Prahallad, Hugo M. Horlings, Irıs D. Nagtegaal, Roderick L. Beijersbergen, René Bernards · 2014 · Oncogene
  25. Epigenetic control of early neurodegenerative events in diabetic retinopathy by the histone deacetylase SIRT 6
    María Aurelia Zorrilla-Zubilete, Ada Yeste, Francisco Javier Quintana, Debra Toiber, Raúl Mostoslavsky, Dafne Magalı́ Silberman · 2017 · Journal of Neurochemistry
  26. ROS-Mediated Apoptotic Cell Death of Human Colon Cancer LoVo Cells by Milk δ-Valerobetaine
    Nunzia D’Onofrio, Nunzio Antonio Cacciola, Elisa Martino, Francesca Borrelli, Ferdinando Fiorino, Assunta Lombardi, Gianluca Neglia, Maria Luisa Balestrieri, Giuseppe Campanile · 2020 · Scientific Reports
  27. Positioning of nucleosomes containing γ-H2AX precedes active DNA demethylation and transcription initiation
    Stephanie Dobersch, Karla Rubio, Indrabahadur Singh, Stefan Günther, Johannes Graumann, Julio Cordero, Rafael Castillo‐Negrete, Minh Bao Huynh, Aditi Mehta, Peter Braubach et al. · 2021 · Nature Communications
  28. Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
    Soumik Pal, Amit Kumar Sharma, Sam Padalumavunkal Mathew, Bithiah Grace Jaganathan · 2022 · Frontiers in Immunology
  29. Targeting aberrant cancer metabolism – The role of sirtuins
    Robert Kleszcz, Jarosław Paluszczak, Wanda Baer‐Dubowska · 2015 · Pharmacological Reports
  30. SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice
    Pamela Becherini, Irene Caffa, Francesco Piacente, Patrizia Damonte, Valerio Gaetano Vellone, Mario Passalacqua, Andrea Benzi, Tommaso Bonfiglio, Daniele Reverberi, A. Khalifa et al. · 2021 · Cancer & Metabolism
  31. Expression of SIRT1 and SIRT3 varies according to age in mice
    Young-Ho Kwon, Jong‐Sik Kim, Chae-Yeong Lee, Hyun Kim · 2015 · Anatomy & Cell Biology
  32. Epigenetic mechanisms underlying lifespan and age-related effects of dietary restriction and the ketogenic diet
    Cesar L. Moreno, Charles V. Mobbs · 2016 · Molecular and Cellular Endocrinology
  33. SIRT6 Depletion Suppresses Tumor Growth by Promoting Cellular Senescence Induced by DNA Damage in HCC
    Namgyu Lee, Hye Guk Ryu, Jung‐Hee Kwon, Dae‐Kyum Kim, Sae Rom Kim, Hee-Jung Wang, Kyong‐Tai Kim, Kwan Yong Choi · 2016 · PLoS ONE
  34. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway
    Jianmei Zhou, Ang Wu, Xiaoting Yu, Jianwei Zhu, Hui Dai · 2017 · Oncology Reports
  35. Serum proton NMR metabolomics analysis of human lung cancer following microwave ablation
    Jian-Ming Hu, Huangtao Sun · 2018 · Radiation Oncology
  36. Impact of nutrient overload on metabolic homeostasis
    Haowen Qiu, Vicki L. Schlegel · 2018 · Nutrition Reviews
  37. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling
    Junhong Tian, Leilei Yuan · 2018 · Biomedicine & Pharmacotherapy
  38. The dual role of sirtuins in cancer: biological functions and implications
    Lu Yu, Yanjiao Li, Siyuan Song, Yalin Zhang, Yiping Wang, Hailian Wang, Zhengteng Yang, Yi Wang · 2024 · Frontiers in Oncology
  39. Proteomic analysis of the SIRT6 interactome: novel links to genome maintenance and cellular stress signaling
    Federica Simeoni, Luisa Tasselli, Shinji Tanaka, Lidia Villanova, Mayumi Hayashi, Kazuishi Kubota, Fujio Isono, Benjamin Aaron Garcia, Eriko Michishita-Kioi, Katrin F. Chua · 2013 · Scientific Reports
  40. The RNA-binding protein PCBP2 facilitates gastric carcinoma growth by targeting miR-34a
    Cheng’en Hu, Yong-Chao Liu, Huidong Zhang, Guangjian Huang · 2014 · Biochemical and Biophysical Research Communications
  41. Sirtuin SIRT6 suppresses cell proliferation through inhibition of Twist1 expression in non-small cell lung cancer.
    Zhijun Han, Lei Liu, Yaxin Liu, Shanqing Li · 2014 · Europe PMC (PubMed Central)
  42. SIRT6 Is Involved in the Progression of Ovarian Carcinomas via β-Catenin-Mediated Epithelial to Mesenchymal Transition
    Jun Sang Bae, Sang Jae Noh, Kyoung Min Kim, See‐Hyoung Park, Usama Khamis Hussein, Ho Sung Park, Byung‐Hyun Park, Sang Hoon Ha, Ho Lee, Myoung Ja Chung et al. · 2018 · Frontiers in Oncology
  43. Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia
    Sylvia E. Perez, Jennifer C. Miguel, Bin He, Michael H. Malek‐Ahmadi, Eric E. Abrahamson, Miloš D. Ikonomović, Ira T. Lott, Eric W. Doran, Melissa J. Alldred, Stephen D. Ginsberg et al. · 2019 · Acta Neuropathologica
  44. Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
    Mohammed I. Y. Elmallah, Olivier Micheau · 2019 · Cancers
  45. HDAC10 Regulates Cancer Stem-Like Cell Properties in KRAS-Driven Lung Adenocarcinoma
    Yixuan Li, Xiangyang Zhang, Shaoqi Zhu, Eden A. Dejene, Weiqun Peng, Antonia R. Sepulveda, Edward Seto · 2020 · Cancer Research
  46. A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma
    Jee-Eun Choi, Carlos Sebastián, Christina M. Ferrer, Caroline A. Lewis, Moshe Sade-Feldman, Thomas James LaSalle, Anna L. K. Gonye, Begona G. C. Lopez, Walid M. Abdelmoula, Michael Scott Regan et al. · 2021 · Nature Metabolism
  47. Critical role of TRPC6 in maintaining the stability of HIF-1α in glioma cells under hypoxia
    Shanshan Li, Jinkui Wang, Wei Yi, Yongjian Liu, Xia Ding, Bin Dong, Yinghui Xu, Yizheng Wang · 2015 · Journal of Cell Science
  48. The biological significance of histone modifiers in multiple myeloma: clinical applications
    Hiroto Ohguchi, Teru Hideshima, Kenneth Carl Anderson · 2018 · Blood Cancer Journal
  49. FOXO3a‑SIRT6 axis suppresses aerobic glycolysis in melanoma
    Zhen Dong, Jie Yang, Lin Li, Li Tan, Pengfei Shi, Jiayi Zhang, Xi Zoë Zhong, Lingjun Ge, Zonghui Wu, Hongjuan Cui · 2020 · International Journal of Oncology
  50. Cancer cell metabolism connects epigenetic modifications to transcriptional regulation
    Ashby J. Morrison · 2021 · FEBS Journal
  51. Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis
    Feng Wu, Liangliang Xu, Yalin Tu, Otto Ka-Wing Cheung, Lemuel L. M. Szeto, Myth T.S. Mok, Weiqin Yang, Wei Kang, Qin Cao, Paul B.S. Lai et al. · 2021 · Cancer Letters
  52. Writers, Readers, and Erasers of Epigenetic Marks
    Thomas B. Nicholson, Nicolás Veland, Taiping Chen · 2015 · Elsevier eBooks
  53. Sirtuin 6 suppresses hypoxia‐induced inflammatory response in human osteoblasts via inhibition of reactive oxygen species production and glycolysis—A therapeutic implication in inflammatory bone resorption
    Kuo‐Liang Hou, Sze‐Kwan Lin, Ling‐Hsiu Chao, Eddie Hsiang‐Hua Lai, Cheng‐Chi Chang, Chia‐Tung Shun, Wan‐Yu Lu, Jyh‐Horng Wang, Michael Hsiao, Chi‐Yuan Hong et al. · 2016 · BioFactors
  54. SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects
    Patrizia Damonte, Giovanna Sociali, Marco Daniele Parenti, Debora Soncini, Inga Bauer, Silvia Boero, Alessia Grozio, Maria von Holtey, Francesco Piacente, Pamela Becherini et al. · 2017 · Bioorganic & Medicinal Chemistry
  55. Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective
    Haixiang Pei, Weikai Guo, Yangrui Peng, Hai Xiong, Yihua Chen · 2022 · Medicinal Research Reviews
  56. Epigenetic regulation of NKG2D ligands is involved in exacerbated atherosclerosis development in Sirt6 heterozygous mice
    Zhu‐Qin Zhang, Sichong Ren, Ying Tan, Zuo-Zhi Li, Xiaoqiang Tang, Tingting Wang, De‐Long Hao, Xiang Zhao, Hou‐Zao Chen, De‐Pei Liu · 2016 · Scientific Reports
  57. eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis
    Yan Cheng, Xingcong Ren, Yun Yuan, Y Shan, L Li, Xiaochi Chen, L Zhang, Yoshinori Takahashi, Jun Yang, B Han et al. · 2016 · Oncogene
  58. NAD+ in Cancer Prevention and Treatment: Pros and Cons
    Borut Poljšak · 2016 · Journal of Clinical & Experimental Oncology
  59. Redox modulation of vitagenes via plant polyphenols and vitamin D: Novel insights for chemoprevention and therapeutic interventions based on organoid technology
    Maria Concetta Scuto, Angela Trovato Salinaro, Isabella Caligiuri, Maria Laura Ontario, Valentina Greco, Nello Sciuto, Roberto Crea, Edward J. Calabrese, Flavio Rizzolio, Vincenzo Canzonieri et al. · 2021 · Mechanisms of Ageing and Development
  60. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: Current trends
    Santu Kumar Saha, Anisur Rahman Khuda‐Bukhsh · 2013 · European Journal of Pharmacology
  61. The Many Faces of Sirtuins: Sirtuins and the Warburg effect
    Leonard Guarente · 2014 · Nature Medicine
  62. Emerging role of sirtuins on tumorigenesis: possible link between aging and cancer
    Yong I. Cha, Hyun-Seok Kim · 2013 · BMB Reports
  63. Characterization of physiological defects in adult SIRT6-/- mice
    Victoria Peshti, Alexey Obolensky, Liat Nahum, Yariv Kanfi, MORAN RATHAUS, Maytal Avraham, Simon Tinman, Fredrick W. Alt, Eyal Banin, Haim Yosef Cohen · 2017 · PLoS ONE
  64. Sirtuin 6 plays an oncogenic role and induces cell autophagy in esophageal cancer cells
    Nan Jing Huang, Zhiwei Liu, Jiabei Zhu, Zhongqi Cui, Yuguang Li, Yongchun Yu, Fenyong Sun, Qiuhui Pan, Qingyuan Yang · 2017 · Tumor Biology
  65. Role of Sirtuins in Tumor Angiogenesis
    Lincy Edatt, Aswini Poyyakkara, Grace R. Raji, Vishnu Ramachandran, Sarojini Sharath Shankar, V.B. Sameer Kumar · 2020 · Frontiers in Oncology
  66. Post-Translational Modification of Proteins in Toxicological Research: Focus on Lysine Acylation
    Sangkyu Lee · 2013 · Toxicological Research
  67. A crucial role of SUMOylation in modulating Sirt6 deacetylation of H3 at lysine 56 and its tumor suppressive activity
    Juan Cai, Y Zuo, T Wang, Yanan Cao, Rong Cai, F-L Chen, Jinke Cheng, J Mu · 2016 · Oncogene
  68. Phenotypic research on senile osteoporosis caused by SIRT6 deficiency
    Demao Zhang, Dixin Cui, Ruoshi Xu, Yachuan Zhou, Liwei Zheng, Peng Liu, Xuedong Zhou · 2016 · International Journal of Oral Science
  69. Downregulation of SIRT6 by miR-34c-5p is associated with poor prognosis and promotes colon cancer proliferation through inhibiting apoptosis via the JAK2/STAT3 signaling pathway
    Ning Li, Dong Mao, Yansha Cao, Hua Li, Fu Ren, Keyan Li · 2018 · International Journal of Oncology
  70. MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6.
    Song Shi, Yuxia Yang, Minghui Liu, Boya Liu, Xin Ping Yang, Miao Yu, Hao Qi, Mengmeng Ren, Zhe Wang, Junhua Zou et al. · 2018 · Europe PMC (PubMed Central)
  71. Metabolic reprogramming: a bridge between aging and tumorigenesis
    Drapela, Stanislav, Ilter, Didem, Gomes, Ana P. · 2022 · Molecular Oncology
  72. SIRT7: a novel molecular target for personalized cancer treatment?
    Alessandro Ianni, Poonam Kumari, Shahriar Tarighi, Thomas W Braun, Alejandro Vaquero · 2024 · Oncogene
  73. Histone deacetylases 1 and 2 are required for brain development
    Joanna Jaworska, Małgorzata Ziemka‐Nałęcz, Teresa Zalewska · 2015 · The International Journal of Developmental Biology
  74. Melatonin Modulates the Microenvironment of Glioblastoma Multiforme by Targeting Sirtuin 1
    Sheng‐Wei Lai, Yu-Shu Liu, Dah‐Yuu Lu, Cheng‐Fang Tsai · 2019 · Nutrients
  75. Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune response
    Ziqi Ye, Jie Chen, Ping Cheong Huang, Zixue Xuan, Shuilian Zheng · 2022 · Frontiers in Oncology
  76. Sirt6 Promotes DNA End Joining in iPSCs Derived from Old Mice
    Wen Chen, Nana Liu, Hongxia Zhang, Haiping Zhang, Jing Qiao, Wenwen Jia, Songcheng Zhu, Zhiyong Mao, Jiuhong Kang · 2017 · Cell Reports
  77. Sirt6 deletion in bone marrow-derived cells increases atherosclerosis – Central role of macrophage scavenger receptor 1
    Tasneem Arsiwala, Jürgen Pahla, Lambertus J. van Tits, Lavinia Bisceglie, Daniel S. Gaul, Sarah Costantino, Melroy X Miranda, Kathrin Nussbaum, Simona Stivala, Przemysław Błyszczuk et al. · 2020 · Journal of Molecular and Cellular Cardiology
  78. Discovery of Potent Small-Molecule SIRT6 Activators: Structure–Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity
    Xiuli Chen, Weining Sun, Shenzhen Huang, Hailin Zhang, Guifeng Lin, Hui Li, Jingxin Qiao, Linli Li, Shengyong Yang · 2020 · Journal of Medicinal Chemistry
  79. A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine
    Carlos Sebastián, Christina M. Ferrer, Maria Serra, Jee-Eun Choi, Nadia Ducano, Alessia Mira, Manasvi S. Shah, Sylwia A. Stopka, Andrew J. Perciaccante, Claudio Isella et al. · 2022 · Nature Communications
  80. RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative phosphorylation and glycolysis
    Wenshu Chen, Q Wang, Liping Bai, Wenshu Chen, X Wang, Carmen S. Tellez, Shuai Leng, Mabel T. Padilla, Toru Nyunoya, Steven A. Belinsky et al. · 2014 · Cell Death and Differentiation
  81. The role of SIRT6 in tumors
    Vanessa Desantis, Aurelia Lamanuzzi, Angelo Vacca · 2017 · Haematologica
  82. The role of mammalian sirtuins in cancer metabolism
    Carlos Sebastián, Raúl Mostoslavsky · 2015 · Seminars in Cell and Developmental Biology
  83. The Oxidative State of Cysteine Thiol 144 Regulates the SIRT6 Glucose Homeostat
    David L. Long, Hanzhi Wu, Allen W. Tsang, Leslie B. Poole, Barbara K. Yoza, Xianfeng Wang, Vidula Vachharajani, Cristina M. Furdui, Charles E. McCall · 2017 · Scientific Reports
  84. SIRT6 promotes the Warburg effect of papillary thyroid cancer cell BCPAP through reactive oxygen species
    Weiping Yu, Yang Zhou, Renhong Huang, Zhijun Min, Min Ye · 2019 · OncoTargets and Therapy
  85. Sirtuin Modulators in Cellular and Animal Models of Human Diseases
    Jun Young Hong, Hening Lin · 2021 · Frontiers in Pharmacology
  86. Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth
    Yizheng Zhang, Chuchu Zhang, Jiehan Li, Meimei Jiang, Shuning Guo, Ge Yang, Lingling Zhang, Feng Wang, Shiqi Yi, Jiangang Wang et al. · 2022 · Cell Communication and Signaling
  87. Metabolism–epigenome crosstalk in physiology and diseases
    Shinjiro Hino, Katsuya Nagaoka, Mitsuyoshi Nakao · 2013 · Journal of Human Genetics
  88. A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance
    Chandrima Das, Apoorva Bhattacharya, Swagata Adhikari, Atanu Mondal, Payel Mondal, Santanu Adhikary, Siddhartha Roy, Kenneth S. Ramos, Kamlesh Kumar Yadav, John A. Tainer et al. · 2024 · Oncogene
  89. Sirtuins in metabolism, stemness and differentiation
    Marcelo Correia, Tânia Perestrelo, Ana Sofia Rodrigues, Marcelo F. Ribeiro, Sandro L. Pereira, Maria Inês Sousa, João Ramalho‐Santos · 2016 · Biochimica et Biophysica Acta (BBA) - General Subjects
  90. Differential expression of the sirtuin family in renal cell carcinoma: Aspects of carcinogenesis and prognostic significance
    Seong Uk Jeh, Jung Je Park, Jong Sil Lee, Dong Chul Kim, Jungmo Do, Sin Woo Lee, See Min Choi, Jae Seog Hyun, Deok Ha Seo, Chunwoo Lee et al. · 2017 · Urologic Oncology Seminars and Original Investigations
  91. Inhibition of cell invasion and migration by targeting matrix metalloproteinase-9 expression via sirtuin 6 silencing in human breast cancer cells
    On‐Yu Hong, Hye‐Yeon Jang, Young‐Rae Lee, Sung Hoo Jung, Hyun Jo Youn, Jong‐Suk Kim · 2022 · Scientific Reports
  92. Putative tumor suppression function of SIRT6 in endometrial cancer
    Tomohiko Fukuda, Osamu Wada‐Hiraike, Katsutoshi Oda, Michihiro Tanikawa, Chinami Makii, Kanako Inaba, Aki Miyasaka, Yuichiro Miyamoto, Tetsu Yano, Daichi Maeda et al. · 2015 · FEBS Letters
  93. Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression
    Fikret Rifatbegovic, Christian Frech, M. Reza Abbasi, Sabine Taschner‐Mandl, Tamara Weiss, Wolfgang M. Schmidt, Iris Schmidt, Ruth Lydia Ladenstein, Inge M. Ambros, Peter F. Ambros · 2017 · International Journal of Cancer
  94. Downregulated SIRT6 and upregulated NMNAT2 are associated with the presence, depth and stage of colorectal cancer
    Qi Jia, Chunhui Cui, Quanwen Deng, Lifeng Wang, Rihong Chen, Duanyang Zhai, Lang Xie, Jinlong Yu · 2018 · Oncology Letters
  95. Mechanism of activation for the sirtuin 6 protein deacylase
    Mark A. Klein, Can Liu, Vyacheslav I. Kuznetsov, John B. Feltenberger, Weiping Tang, John M. Denu · 2019 · Journal of Biological Chemistry
  96. α-Hederin inhibits the growth of lung cancer A549 cells in vitro and in vivo by decreasing SIRT6 dependent glycolysis
    Cong Fang, Yahui Liu, Lanying Chen, Yingying Luo, Yaru Cui, Ni Zhang, Peng Liu, Mengjing Zhou, Yongyan Xie · 2020 · Pharmaceutical Biology
  97. The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma
    Xin Chen, Bin Hao, Ying Liu, Dongwei Dai, Guosheng Han, Yanan Li, Xi Lawrence Wu, Xiaoping Zhou, Zhijian Yue, Laixing Wang et al. · 2014 · Biochemical and Biophysical Research Communications
  98. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death
    Xingran Jiang, Xiying Yu, Jin‐Hu Fan, Liping Guo, Changjun Zhu, Wei Bo Jiang, Shih‐Hsin Lu · 2014 · Cancer Letters
  99. Haploinsufficiency of Trp53 dramatically extends the lifespan of Sirt6-deficient mice
    Shrestha Ghosh, Sheung Kin Ken Wong, Zhixin Jiang, Baohua Liu, Yi Wang, Quan Hao, Vera A. Gorbunova, Xinguang Liu, Zhongjun Zhou · 2018 · eLife
  100. Human height genes and cancer
    Romina Tripaldi, Liborio Stuppia, Saverio Alberti · 2013 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer